Hackensack Meridian Health Invests in EpiBone, Inc., A Regenerative Medicine Company
May 19, 2020
Hackensack Meridian Health has invested in EpiBone, Inc., a biotechnology company targeting the growth of personalized bone and cartilage grafts using stem cell technologies and 3D imaging and designs.
This investment in a clinical-stage regenerative medicine company is Hackensack Meridian Health’s fourth through the Bear’s Den, the health network’s successful innovation program.